Fortress Biotech, Inc. - Insider Non-Derivative Transactions at AVENUE THERAPEUTICS, INC. (ATXI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Apr 16, 2024, Fortress Biotech, Inc.'s relationship to AVENUE THERAPEUTICS, INC. (ATXI) is TenPercentOwner, and currently has 3,547,393 shares of COMMON STOCK, PAR VALUE $0.0001, and 1,032,390 shares of Common Stock.
The the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ATXI insiders.
Data Source: SEC.
Fortress Biotech, Inc. - Insider Non-Derivative Transactions of ATXI COMMON STOCK, PAR VALUE $0.0001
Fortress Biotech, Inc. - Insider Non-Derivative Transactions at ATXI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Apr 17, 2024 | Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) | 413507 | 0 | 3547393 |
| Jan 3, 2024 | Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) | 2101496 | 0 | 3133886 |
| Sep 9, 2023 | P -- (Common Stock) | 418410 | 0.72 | 1032390 |
| Apr 1, 2023 | Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) | 52419 | 0 | 613980 |
| Jan 4, 2023 | Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) | 231316 | 0 | 561561 |
| Jan 1, 2023 | Acquisition -- (COMMON STOCK, PAR VALUE $0.0001) | 90909 | 0 | 330245 |